The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-176832.87 MB324页
2024-07-1767755.71 KB17页26
2024-07-1767645.2 KB6页23
2024-07-17671.93 MB63页17
2024-07-196714.05 MB785页2
2024-07-196726.03 MB194页28
2024-07-19673.94 MB100页11
2024-07-19672.69 MB40页11
2024-07-1967887.61 KB39页14
2024-07-19672 MB24页4
2024-07-19673.44 MB42页28
2024-07-1967616.41 KB54页18
2024-07-19671.71 MB31页20
2024-07-1967293.43 KB15页31
2024-07-19671.19 MB28页4
2024-07-19671.92 MB51页26
2024-07-1967330 KB14页15
2024-07-216725.5 KB1页7
2024-07-2167163.47 KB6页28
2024-07-2167152.51 KB2页12